Measuring exacerbations in obstructive lung disease-Reference-Cited by-同舟云学术

Measuring exacerbations in obstructive lung disease

Published:2009-12-14 Issue:4 Volume:19 Page:367-374
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidem. Drug Safe.

Author:

Velthove Karin J.,Souverein Patrick C.,van Solinge Wouter W.,Leufkens Hubert G. M.,Lammers Jan-Willem J.

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.1892/fullpdf

Reference38 articles.

1. From the Global Strategy for the Diagnosis Management and Prevention of COPD Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2008 http://www.goldcopd.org

2. From the Global Strategy for Asthma Management and Prevention Global Initiative for Asthma (GINA) 2008 http://www.ginasthma.org

3. Global burden of COPD: systematic review and meta-analysis;Halbert;Eur Respir J,2006

4. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial;Siva;Eur Respir J,2007

5. Asthma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tutorial: Strategies addressing detection bias were reviewed and implemented for investigating the statins–diabetes association;Journal of Clinical Epidemiology;2015-05

2. Burden of Exacerbations in Patients with Moderate to Very Severe COPD in the Netherlands: A Real-life Study;COPD: Journal of Chronic Obstructive Pulmonary Disease;2014-06-24

3. Increased Risk of Sudden Cardiac Arrest in Obstructive Pulmonary Disease: A Case-Control Study;PLoS ONE;2013-06-06

4. Current World Literature;Current Opinion in Pulmonary Medicine;2011-01

5. Current awareness: Pharmacoepidemiology and drug safety;Pharmacoepidemiology and Drug Safety;2010-08-25